Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Drug Discovery

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1354689

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1354689

ADME-Toxicology Testing

PUBLISHED:
PAGES: 472 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5600
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 16800

Add to Cart

Description

Table of Contents

What`s New?

» Special discussions on the global economic climate and market sentiment

» Coverage on global competitiveness and key competitor percentage market shares

» Market presence analysis across multiple geographies - Strong/Active/Niche/Trivial

» Online interactive peer-to-peer collaborative bespoke updates

» Access to our digital archives and MarketGlass™ research platform

» Complimentary updates for one year

» Access to curated YouTube video transcripts of market sentiments shared by CEOs, domain experts and market influencers via interviews, podcasts, press statements and event keynotes

Economic Outlook

The global economic outlook is improving, and growth recovery, albeit on the lower side, is expected for this year and the next. The United States although witnessing slowing GDP growth in response to tight monetary and financial conditions, has nevertheless overcome the recession threat. Easing of headline inflation in Euro area is helping boost real incomes and is contributing to pick-up in economic activity. China is expected to see strong increases in GDP in the coming year as the pandemic threat recedes and the government sheds its zero-COVID policy. With optimistic GDP projections, India remains on-course to emerge into a US$6 trillion economy by 2030, surpassing Japan and Germany.

The upturn, however, remains fragile and a number of interlocking challenges continue to run in parallel, such as continued uncertainty around the war in Ukraine; slower than expected decline in global headline inflation; continuation of food and fuel inflation as a persistent economic problem for most developing countries; and still high retail inflation and its impact on consumer confidence and spending. Countries and their governments are showing signs of weathering these challenges, which helps lift market sentiments. As governments continue to combat inflation to get it down to more economically conformable levels by raising interest rates, new job creation will slowdown and impact economic activity. Stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced.

Although corporate investments can likely be held back by inflation worries and weaker demand, rise of new technologies will reverse partially this prevailing investment sentiment. Rise of generative AI; applied AI; industrializing machine learning; next-generation software development; Web3; cloud and edge computing; quantum technologies; electrification and renewables and climate technologies beyond electrification and renewables, will open up the global investment landscape. The technologies hold the potential to drive sizeable incremental growth and value to global GDP in the coming years. The short-term is expected to be a mixed bag of challenges and opportunities for both consumers and investors alike. There is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global ADME-Toxicology Testing Market to Reach $17.3 Billion by 2030

The global market for ADME-Toxicology Testing estimated at US$7.7 Billion in the year 2022, is projected to reach a revised size of US$17.3 Billion by 2030, growing at a CAGR of 10.6% over the period 2022-2030. Cell Culture, one of the segments analyzed in the report, is projected to record 12.6% CAGR and reach US$8.8 Billion by the end of the analysis period. Growth in the High Throughput Screening segment is estimated at 7.4% CAGR for the next 8-year period.

The U.S. Market is Estimated at $3.8 Billion, While China is Forecast to Grow at 14% CAGR

The ADME-Toxicology Testing market in the U.S. is estimated at US$3.8 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.5 Billion by the year 2030 trailing a CAGR of 14% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.4% and 11.6% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 10.1% CAGR.

Select Competitors (Total 79 Featured) -

  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Corning, Inc.
  • BD Biosciences
  • Charles River Laboratories International, Inc.
  • AB Sciex LLC
  • Dassault Systemes SE (3DS)
  • Cyprotex Limited
  • BioReliance Corporation
  • Crown Bioscience, Inc.
  • Envigo, Inc.
  • ADMEcell, Inc.
  • Endonovo Therapeutics, Inc.
  • CN Bio Innovations Ltd.
  • Emulate, Inc.
Show more
Product Code: MCP-7635

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • ADME-Toxicology Testing - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
    • ADME-Tox : An Introduction
    • A Prelude to ADME Toxicology Testing
    • Impact of Covid-19 and a Looming Global Recession
    • 2020 Marked as a Year of Disruption & Transformation
    • As the Race between the Virus & Vaccines Intensifies, Where is the World Economy Headed in 2021
    • World Economic Growth Projections (Real GDP, Annual % Change) for 2020 through 2022
    • COVID-19 IMPACT ON ADME TOXICOLOGY TESTING MARKET
    • Global Market Prospects and Growth Drivers
    • Drug Makers Bet on ADME & Toxicology Testing to Improve Success Rate for Potential Drug Candidates
    • Cell Culture Holds a Major Share of the Market
    • North America and Europe Dominate, Asia-Pacific Witnesses Rapid Growth
    • Competition
    • Recent Market Activity
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increased Need to Check Late-Stage Drug Failures Drive Market Growth
    • Steady Increase in Average Drug Development Cost and Efforts to Mitigate Late-Stage Drug Failure Rates Highlights the Role of ADME-Toxicology Testing: Average Cost of Drug Development (in US$ Billion) in the US since 1980s
    • Impact of ADME-Tox Screening on New Drug Discovery
    • TABLE 1: Phase-I Clinical Trial Failures Before and After the Advent of Preclinical ADME/Pharmacokinetics
    • actors Leading to Failure of Drugs in Phase III Clinical Trials: Percentage Breakdown of Number of Cases for Efficacy, Pharmacokinetics, Toxicity and Others
    • Drug Withdrawals Due to Toxicity Issues (1990-early 2010s): Percentage Share Breakdown of Number of Drugs Withdrawn Due to Cardiotoxicity, Hepatotoxicity and Others
    • Pharma Industry Renews Focus on Cost Optimization
    • Global Pharmaceutical R&D Spending (US$ Billion) for the Years 2011 through 2020
    • New FDA Approvals (2010-2020): Breakdown of Number of Approvals by Type for New Molecular Entity (NME) and Biologic License Application (BLA) Approvals
    • China and India: Hot Spots for R&D Investment
    • World R&D Market by Geographic Region (2020): Percentage Breakdown of R&D Spending for Asia, Europe, Middle East & Africa, North America and South America
    • Growth Momentum Shifts Away from In Vivo Technologies; In Vitro Technologies to Lead the Charge
    • Growing Prominence of Cell-based Assays in Drug Discovery and ADME Analysis
    • Global Cell-based Assays Market by Segment (2020): Percentage Share Breakdown of Value Sales for Consumables, Instruments, Software, and Services
    • Global Market for Cell-based Assays by End-User (2020): Percentage Share Breakdown of Value Sales for Pharma & Biotech Companies, Government & Academic Institutes, CROs, and Others
    • World Cell-based Assays Market by Application (2020): Percentage Breakdown of Revenue for ADME, Basic Research and Drug Discovery
    • Major Types of Cell-Based HTS Assays for Drug Screening
    • Cell-based Assays in HTS and UHTS
    • Innovation in Screening Guarantees Success for Drug Discovery Programs
    • High-Content Screening (HCS) - An Expanding Technology in Cell-Based Assays
    • High Content Screening - Key Application Areas
    • HCS Market Ripe with Growth Opportunity
    • HCS vs. HTS
    • Increasing Use of Cell-Based Assays over Other Methods in Toxicity Testing
    • 3D Cell Culture Technology to Put a New Spin on In Vitro Cell Analyses
    • CDER's DARS 2-Microphysiological 3D Cell Culture Platforms as Drug Development Tools
    • Rising Investment in Proteomics R&D Drive Cell-based Assays Market
    • Automated Multiplexing Platforms Present Growth Opportunities
    • Automation of Cell-based Assays: A Growing Trend
    • In-Silico ADME Emerge as Compelling Drug Discovery & Development Tool
    • Advantages of Using In Silico Approaches
    • Personalized Treatments & Computational Tools: Intriguing Facets of ADME R&D ADME Pharmacogenomics to Power Personalized Treatments
    • ADME Research & Emerging Computational Tools
    • Omics Technology
    • Adoption of Omics-based Technologies
    • In Vitro 3D Organoid Models to Meet ADME-Toxicity Testing Needs
    • Limitations of Traditional in vitro Cellular Models
    • Organoids Technology-Advanced in vitro 3D Platforms for More Physiologically Relevant Modeling
    • Stem Cells Exude Great Potential in Drug Toxicity Testing
    • Global Market for Stem Cell-Assays
    • Functional Assays: An Effective Way of Predicting Specific Toxic Effects
    • GPCR Targets to Drive Growth in Functional Cell Assay Market
    • Molecular Imaging and ADME
    • Organ-on-a-Chip Technology Gains Momentum in ADME Toxicology Testing
    • Technological Advancements in ADME Toxicology Testing
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Cell Culture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Cell Culture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 3: World 16-Year Perspective for Cell Culture by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for High Throughput Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 5: World Historic Review for High Throughput Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 6: World 16-Year Perspective for High Throughput Screening by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Molecular Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Molecular Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 9: World 16-Year Perspective for Molecular Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for OMICS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 11: World Historic Review for OMICS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 12: World 16-Year Perspective for OMICS by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 15: World 16-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Cellular Assay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Cellular Assay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 18: World 16-Year Perspective for Cellular Assay by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Biochemical Assay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Biochemical Assay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 21: World 16-Year Perspective for Biochemical Assay by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Ex-Vivo by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Ex-Vivo by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 24: World 16-Year Perspective for Ex-Vivo by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for In Silica by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 26: World Historic Review for In Silica by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 27: World 16-Year Perspective for In Silica by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Systemic Toxicity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Systemic Toxicity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 30: World 16-Year Perspective for Systemic Toxicity by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 31: World Recent Past, Current & Future Analysis for Renal Toxicity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 32: World Historic Review for Renal Toxicity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 33: World 16-Year Perspective for Renal Toxicity by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 34: World Recent Past, Current & Future Analysis for Hepatotoxicity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 35: World Historic Review for Hepatotoxicity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 36: World 16-Year Perspective for Hepatotoxicity by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 37: World Recent Past, Current & Future Analysis for Neurotoxicity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 38: World Historic Review for Neurotoxicity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 39: World 16-Year Perspective for Neurotoxicity by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 40: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 41: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 42: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 43: World ADME-Toxicology Testing Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 44: World Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 45: World Historic Review for ADME-Toxicology Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 46: World 16-Year Perspective for ADME-Toxicology Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2023 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • ADME-Toxicology Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 47: USA Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 49: USA 16-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 50: USA Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 52: USA 16-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2014, 2023 & 2030
    • TABLE 53: USA Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 54: USA Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 55: USA 16-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2014, 2023 & 2030
  • CANADA
    • TABLE 56: Canada Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 58: Canada 16-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 59: Canada Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 61: Canada 16-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2014, 2023 & 2030
    • TABLE 62: Canada Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 63: Canada Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 64: Canada 16-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2014, 2023 & 2030
  • JAPAN
    • ADME-Toxicology Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 65: Japan Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 67: Japan 16-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 68: Japan Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 70: Japan 16-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2014, 2023 & 2030
    • TABLE 71: Japan Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 72: Japan Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 73: Japan 16-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2014, 2023 & 2030
  • CHINA
    • ADME-Toxicology Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 74: China Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 75: China Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 76: China 16-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 77: China Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 78: China Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 79: China 16-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2014, 2023 & 2030
    • TABLE 80: China Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 81: China Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 82: China 16-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2014, 2023 & 2030
  • EUROPE
    • ADME-Toxicology Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 83: Europe Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 85: Europe 16-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 88: Europe 16-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2014, 2023 & 2030
    • TABLE 89: Europe Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 91: Europe 16-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 92: Europe Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 93: Europe Historic Review for ADME-Toxicology Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 94: Europe 16-Year Perspective for ADME-Toxicology Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2023 & 2030
  • FRANCE
    • ADME-Toxicology Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 95: France Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 96: France Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 97: France 16-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 98: France Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 99: France Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 100: France 16-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2014, 2023 & 2030
    • TABLE 101: France Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 102: France Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 103: France 16-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2014, 2023 & 2030
  • GERMANY
    • ADME-Toxicology Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 104: Germany Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 106: Germany 16-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 107: Germany Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 108: Germany Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 109: Germany 16-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2014, 2023 & 2030
    • TABLE 110: Germany Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 111: Germany Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 112: Germany 16-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2014, 2023 & 2030
  • ITALY
    • TABLE 113: Italy Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 115: Italy 16-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 116: Italy Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 117: Italy Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 118: Italy 16-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2014, 2023 & 2030
    • TABLE 119: Italy Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 120: Italy Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 121: Italy 16-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2014, 2023 & 2030
  • UNITED KINGDOM
    • ADME-Toxicology Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 122: UK Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 124: UK 16-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 125: UK Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 126: UK Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 127: UK 16-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2014, 2023 & 2030
    • TABLE 128: UK Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 129: UK Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 130: UK 16-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2014, 2023 & 2030
  • SPAIN
    • TABLE 131: Spain Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 132: Spain Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 133: Spain 16-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 134: Spain Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 135: Spain Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 136: Spain 16-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2014, 2023 & 2030
    • TABLE 137: Spain Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 138: Spain Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 139: Spain 16-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2014, 2023 & 2030
  • RUSSIA
    • TABLE 140: Russia Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 141: Russia Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 142: Russia 16-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 143: Russia Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 144: Russia Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 145: Russia 16-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2014, 2023 & 2030
    • TABLE 146: Russia Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 147: Russia Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 148: Russia 16-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2014, 2023 & 2030
  • REST OF EUROPE
    • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 150: Rest of Europe Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 151: Rest of Europe 16-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 153: Rest of Europe Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 154: Rest of Europe 16-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2014, 2023 & 2030
    • TABLE 155: Rest of Europe Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 156: Rest of Europe Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 157: Rest of Europe 16-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2014, 2023 & 2030
  • ASIA-PACIFIC
    • ADME-Toxicology Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 160: Asia-Pacific 16-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 162: Asia-Pacific Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 163: Asia-Pacific 16-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2014, 2023 & 2030
    • TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 165: Asia-Pacific Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 166: Asia-Pacific 16-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2014, 2023 & 2030
  • LATIN AMERICA
    • ADME-Toxicology Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
    • TABLE 167: Latin America Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 168: Latin America Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 169: Latin America 16-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 170: Latin America Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 171: Latin America Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 172: Latin America 16-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2014, 2023 & 2030
    • TABLE 173: Latin America Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 174: Latin America Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 175: Latin America 16-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2014, 2023 & 2030
  • MIDDLE EAST
    • ADME-Toxicology Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 178: Middle East 16-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 179: Middle East Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 180: Middle East Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 181: Middle East 16-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2014, 2023 & 2030
    • TABLE 182: Middle East Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 183: Middle East Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 184: Middle East 16-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2014, 2023 & 2030
  • AFRICA
    • ADME-Toxicology Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
    • TABLE 185: Africa Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 186: Africa Historic Review for ADME-Toxicology Testing by Technology - Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 187: Africa 16-Year Perspective for ADME-Toxicology Testing by Technology - Percentage Breakdown of Value Sales for Cell Culture, High Throughput Screening, Molecular Imaging, OMICS and Other Technologies for the Years 2014, 2023 & 2030
    • TABLE 188: Africa Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 189: Africa Historic Review for ADME-Toxicology Testing by Method - Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 190: Africa 16-Year Perspective for ADME-Toxicology Testing by Method - Percentage Breakdown of Value Sales for Cellular Assay, Biochemical Assay, Ex-Vivo and In Silica for the Years 2014, 2023 & 2030
    • TABLE 191: Africa Recent Past, Current & Future Analysis for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 192: Africa Historic Review for ADME-Toxicology Testing by Application - Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 193: Africa 16-Year Perspective for ADME-Toxicology Testing by Application - Percentage Breakdown of Value Sales for Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications for the Years 2014, 2023 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!